TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK4(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant human CLK4 expressed in baculovirus infected Sf21 cellsMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK4(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant human CLK4 expressed in baculovirus infected Sf21 cellsMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair